Invivyd Inc. (IVVD) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.70
• Market Cap: $482.20M
• EPS: $-0.45
• 52-Week High: $3.07
• 52-Week Low: $0.46

Market Sentiment

Invivyd Inc. currently has a Neutral sentiment score of 0.12.

About Invivyd Inc.

Invivyd Inc. is a clinical-stage biopharmaceutical firm headquartered in Waltham, Massachusetts, focused on the discovery and development of cutting-edge antibody-based therapies for infectious diseases. Leveraging proprietary technologies and deep expertise in immunology, the company is committed to addressing substantial unmet medical needs through its robust pipeline of innovative solutions. By positioning itself at the forefront of antibody therapy advancements, Invivyd is well-equipped t...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Invivyd Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does IVVD pay dividends?

Invivyd Inc. (IVVD) does not currently pay a regular dividend.

What is IVVD's market cap?

Invivyd Inc. (IVVD) has a market capitalization of $482.20M with a current stock price of $1.70.